Free Trial

Clorox (NYSE:CLX) Shares Acquired Rep. Lisa C. McClain

Clorox logo with Consumer Staples background

Key Points

  • Representative Lisa C. McClain purchased shares of The Clorox Company (NYSE:CLX) valued between $1,001 and $15,000 in June 2023, according to a filing disclosed on August 13th.
  • The Clorox Company reported earnings per share of $2.87 for the last quarter, exceeding expectations by $0.63, and announced a quarterly dividend increase to $1.24.
  • Institutional investors have shown increased interest in Clorox, with 78.53% of its stock owned by hedge funds and other institutions.
  • Five stocks to consider instead of Clorox.

Representative Lisa C. McClain (R-Michigan) recently bought shares of The Clorox Company NYSE: CLX. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Clorox stock on June 24th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
  • Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
  • Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
  • Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
  • Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.

Clorox Trading Down 1.2%

Shares of Clorox stock traded down $1.4460 during trading on Thursday, reaching $119.8040. 1,753,373 shares of the company were exchanged, compared to its average volume of 1,907,487. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a twelve month low of $117.35 and a twelve month high of $171.37. The business has a 50-day moving average price of $124.31 and a 200-day moving average price of $135.57. The firm has a market capitalization of $14.65 billion, a price-to-earnings ratio of 18.37, a P/E/G ratio of 0.97 and a beta of 0.49.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. During the same period in the previous year, the firm earned $1.82 earnings per share. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Investors of record on Wednesday, August 13th will be paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date of this dividend is Wednesday, August 13th. Clorox's payout ratio is presently 76.07%.

Analyst Upgrades and Downgrades

CLX has been the subject of a number of analyst reports. Evercore ISI set a $140.00 price objective on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Citigroup reiterated a "neutral" rating and set a $135.00 target price (down from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Morgan Stanley reduced their target price on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Wells Fargo & Company lifted their target price on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a report on Friday, August 1st. Finally, Jefferies Financial Group reduced their target price on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. One analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Reduce" and a consensus target price of $143.36.

Read Our Latest Stock Report on CLX

Institutional Trading of Clorox

A number of institutional investors have recently modified their holdings of the company. Sonora Investment Management Group LLC lifted its holdings in shares of Clorox by 2.5% in the first quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company's stock valued at $433,000 after purchasing an additional 72 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of Clorox by 0.6% in the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company's stock valued at $1,953,000 after purchasing an additional 73 shares in the last quarter. Horizon Investments LLC lifted its holdings in shares of Clorox by 4.4% in the first quarter. Horizon Investments LLC now owns 1,768 shares of the company's stock valued at $258,000 after purchasing an additional 75 shares in the last quarter. Sfmg LLC lifted its holdings in shares of Clorox by 2.8% in the first quarter. Sfmg LLC now owns 2,780 shares of the company's stock valued at $409,000 after purchasing an additional 76 shares in the last quarter. Finally, Hancock Whitney Corp lifted its holdings in shares of Clorox by 4.3% in the first quarter. Hancock Whitney Corp now owns 2,064 shares of the company's stock valued at $304,000 after purchasing an additional 86 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Clorox

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.